← Leaderboards
Paul Michael Armistead
Univ Of North Carolina Chapel Hill
$4,318,850
Attributed
$7,460,632
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2012–23$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,460,632 · 4
By mechanism
R01$5,461,362 · 2
R42$1,603,006 · 1
K08$396,264 · 1
Top collaborators
- Nancy L Allbritton7 shared
- Shawn Gomez5 shared
- Qisheng Zhang5 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Stanley M Lemon$138,701,971
- Gianpietro Dotti$17,018,250
- Shawn Gomez$2,863,249
- Qisheng Zhang$4,632,517
- Benyam Muluneh$581,624
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsLeukemiaProductionSamplingProteinsMalignant NeoplasmsCell LineMortalityGenesMutationPathway InteractionsAcute LeukemiaAcute Myelocytic LeukemiaCell ModelCollaborationsIn Complete RemissionImmunotherapyPeptidesPlayLeukemic CellGeneticNorth CarolinaAllogenicLaboratories
Grant awards (15)
MICROFABRICATED INSTRUMENTATION TO MEASURE SPHINGOLIPID SIGNALING IN HUMAN ACUTE MYELOID LEUKEMIA$632,409
R01 · FY2023 · CA
MICROFABRICATED INSTRUMENTATION TO MEASURE SPHINGOLIPID SIGNALING IN HUMAN ACUTE MYELOID LEUKEMIA$632,757
R01 · FY2022 · CA
MICROFABRICATED INSTRUMENTATION TO MEASURE SPHINGOLIPID SIGNALING IN HUMAN ACUTE MYELOID LEUKEMIA$644,104
R01 · FY2021 · CA
MICROFABRICATED INSTRUMENTATION TO MEASURE SPHINGOLIPID SIGNALING IN HUMAN ACUTE MYELOID LEUKEMIA$624,345
R01 · FY2020 · CA
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy$450,736
R01 · FY2020 · CA · contact PI
Microfabricated instrumentation to measure sphingolipid signaling in human acute myeloid leukemia$586,757
R01 · FY2019 · CA
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy$456,823
R01 · FY2019 · CA · contact PI
CellRaft Array for Screening and Isolation of Highly Effective Cytotoxic T Cells$801,617
R42 · FY2018 · AI · contact PI
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy$490,809
R01 · FY2018 · CA · contact PI
CellRaft Array for Screening and Isolation of Highly Effective Cytotoxic T Cells$801,389
R42 · FY2017 · AI · contact PI
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy$500,397
R01 · FY2017 · CA · contact PI
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy$442,225
R01 · FY2016 · CA · contact PI
Leukemia Stem Cell Antigen Discovery Using Advanced Genomic and Proteomic Methods$132,088
K08 · FY2014 · HL · contact PI
Leukemia Stem Cell Antigen Discovery Using Advanced Genomic and Proteomic Methods$132,088
K08 · FY2013 · HL · contact PI
Leukemia Stem Cell Antigen Discovery Using Advanced Genomic and Proteomic Methods$132,088
K08 · FY2012 · HL · contact PI